Ketamine modulates disrupted in schizophrenia-1/glycogen synthase kinase-3β interaction.
Saved in:
| Title: | Ketamine modulates disrupted in schizophrenia-1/glycogen synthase kinase-3β interaction. |
|---|---|
| Authors: | Liu JR; Department of Clinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China., Han XH; Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, MA, United States., Yuki K; Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, MA, United States.; Department of Anaesthesia, Harvard Medical School, Boston, MA, United States., Soriano SG; Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, MA, United States.; Department of Anaesthesia, Harvard Medical School, Boston, MA, United States. |
| Source: | Frontiers in molecular neuroscience [Front Mol Neurosci] 2024 May 22; Vol. 17, pp. 1342233. Date of Electronic Publication: 2024 May 22 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477914 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5099 (Print) Linking ISSN: 16625099 NLM ISO Abbreviation: Front Mol Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
